Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > IDK...

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Jan 22, 2023 10:32am

296 Views

Post# 35238398

RE:RE:RE:RE:RE:IDK...

Not disingenuous but reality.

Tigris is a 3b confirmatory add-on trial, whose results must be combined with Euphrates results in the final data analysis ( and likely at Interim data analysis )

Also a reality that 2020 to mid 2022 was pretty much a write-off period for any ICU based trials. But with a weak pace of late, I agree that some creative changes ( other than adding or modyifying sites) are needed...stat.

Let's see if FA80 does its job or whether they prefer, for the short-term to relish in the symbiosis with the full knowledge that this will inexorably culminate in a prosperous denouement.

MM

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario